Insights into LINE-1 reverse transcription guide therapy development

Nicholas M. Zehrbach,Nakyung Oh,Charles A. Ishak
DOI: https://doi.org/10.1016/j.trecan.2024.02.010
IF: 19.161
2024-04-10
Trends in Cancer
Abstract:Subsets of long interspersed nuclear element 1 (LINE-1) retrotransposons can 'retrotranspose' throughout the human genome at a cost to host cell fitness, as observed in some cancers. Pharmacological inhibition of LINE-1 retrotransposition requires a comprehensive understanding of the LINE-1 ORF2p reverse transcriptase. Two recent publications, by Thawani et al. and Baldwin et al., report structures of LINE-1 ORF2p and address long-standing mechanistic gaps regarding LINE-1 retrotransposition. Both studies will be critical to design new specific inhibitors of the LINE-1 ORF2p reverse transcriptase.
oncology
What problem does this paper attempt to address?